NCT04448886 · Interventional trial
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
Overall registry status Active not recruiting
Phase 2
Conditions HER2-negative Breast Cancer, HR-Positive Breast Cancer, Invasive Breast Cancer, Metastatic Breast Cancer
Delaware Valley sites
- University of Pennsylvania-Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory